Oxaliplatin with high-dose leucovorin (LV) and 5-Fluorouracil (5FU) 48-hour infusion in pretreated metastatic colorectal cancer (FOLFOX6)

被引：0
|
作者：
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles-Amar, V
Izrael, V
Krulik, M
机构：
[1] Hop St Antoine, GERCOR, F-75012 Paris, France
[2] Hop Tenon, F-75020 Paris, France
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
173P
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] CPT11 with high-dose leucovorin (LV) and 5-Fluorouracil (5FU) 48-hour infusion in pretreated metastatic colorectal cancer (FOLFIRI)
    Andre, T
    de Gramont, A
    Louvet, C
    Carola, E
    Maindrault-Goebel, F
    Couteau, C
    Krulik, M
    Izrael, V
    ANNALS OF ONCOLOGY, 1998, 9 : 42 - 42
  • [2] Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer
    deGramont, A
    Vignoud, J
    Tournigand, C
    Louvet, C
    Andre, T
    Varette, C
    Raymond, E
    Moreau, S
    LeBail, N
    Krulik, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (02) : 214 - 219
  • [3] Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer
    Maindrault-Goebel, F
    de Gramont, A
    Louvet, C
    André, T
    Carola, E
    Gilles, V
    Lotz, JP
    Tournigand, C
    Mabro, M
    Molitor, JL
    Artru, P
    Izrael, V
    Krulik, M
    ANNALS OF ONCOLOGY, 2000, 11 (11) : 1477 - 1483
  • [4] Third line oxaliplatin with leucovorin (LV) and continuous infusion 5-fluorouracil (5FU) in metastatic colorectal cancer.
    Abón, G
    Muñoz, A
    Rubio, I
    Mañé, JM
    Ferreiro, J
    Fernández, R
    Fuente, N
    López-Argumedo, G
    Barceló, R
    Vivanco, GL
    ANNALS OF ONCOLOGY, 2000, 11 : 48 - 49
  • [5] Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
    André, T
    Louvet, C
    Raymond, E
    Tournigand, C
    de Gramont, A
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1251 - 1253
  • [6] Oxaliplatin (L-OHP) in combination with leucovorin (LV) and 5-fluorouracil (5FU) in pretreated metastatic colorectal cancer (CRC) patients (PTS).
    Di Stefano, A
    Calandri, C
    Benedetti, G
    Poggi, B
    Mazzoni, F
    Marrocolo, F
    Spagnuolo, P
    Rimondini, S
    Crinò, L
    ANNALS OF ONCOLOGY, 2000, 11 : 68 - 68
  • [7] Does the dose of leucovorin (LV) matter with 5-fluorouracil (5FU) in colorectal cancer (CRC)?
    Biagi, James Joseph
    Coakley, Nadia
    Earle, Craig
    Erlichman, Charles
    Fields, Anthony L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [8] A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer
    Kouroussis, C
    Kalbakis, K
    Androulakis, N
    Agelaki, S
    Vamvakas, L
    Malas, K
    Souglakos, J
    Vardakis, N
    Georgoulias, V
    ANTICANCER RESEARCH, 2004, 24 (06) : 4217 - 4221
  • [9] Oxaliplatin with high-dose folinic acid and 5-fluorouracil 48 H infusion in pretreated metastatic colorectal cancer (CRC)
    deGramont, A
    Vignoud, J
    Tournigand, C
    Louvet, C
    Varette, C
    Raymond, E
    Krulik, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 716 - 716
  • [10] Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer:: a phase II study
    Hegewisch-Becker, S
    Gruber, Y
    Corovic, A
    Pichlmeier, U
    Atanackovic, D
    Nierhaus, A
    Hossfeld, DK
    ANNALS OF ONCOLOGY, 2002, 13 (08) : 1197 - 1204
12345